Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of the Lifestyle Eating and Performance (LEAP) Program for the Treatment of Irritable Bowel Syndrome (IBS)

NCT05178017 is registered in ClinicalTrials.gov with Oxford Biomedical Technologies, Inc. as lead sponsor.

NCT NCT05178017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05178017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of the Lifestyle Eating and Performance (LEAP) Program for the Treatment of Irritable Bowel Syndrome (IBS)
Lead sponsor
Oxford Biomedical Technologies, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 1, 2021
Completion date
December 31, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ibs - irritable bowel syndrome